Breaking News Instant updates and real-time market news.

GALT

Galectin Therapeutics

$4.06

-0.455 (-10.09%)

08:05
08/14/18
08/14
08:05
08/14/18
08:05

Galectin Therapeutics reports Q2 EPS (11c), two estimates (12c)

GALT Galectin Therapeutics
$4.06

-0.455 (-10.09%)

12/07/17
HCWC
12/07/17
NO CHANGE
Target $10
HCWC
Buy
H.C. Wainwright says market wrong, ups Galectin target to $10
H.C. Wainwright analyst Ed Arce raised his price target for Galectin Therapeutics to $10 from $6 saying the market got wrong, "again," the company's Phase 2b NASH-CX trial results, which featured a miss on the overall primary efficacy endpoint. The corresponding stock selloff reflects the "inability of many biotech investors to recognize any value from a trial result that does not myopically present as a 'clean in,'" Arce tells investors in a research note. He believes the study is a "landmark" for the treatment of cirrhosis, "not only because it appears to offer the first ever pharmacological benefit in NASH cirrhosis (across several parameters), but also because it defines a highly clinically significant and easily identifiable patient sub-population for treatment: cirrhotics with mild portal hypertension." The analyst sees multiple paths available to Galectin for a registrational Phase 3 program and he reaffirms his Buy rating on the shares.
12/07/17
ROTH
12/07/17
NO CHANGE
Target $3
ROTH
Buy
Galectin Therapeutics price target lowered to $3 from $10 at Roth Capital
Roth Capital analyst Yasmeen Rahimi lowered her price target for Galectin Therapeutics to $3 from $10 after the company announced that its Phase 2b NASHCX trial in 161 cirrhotic NASH patients missed its primary endpoint. However, the analyst still sees a few positive points such as clean safety, and reiterates a Buy rating on the shares.
01/04/18
ROTH
01/04/18
NO CHANGE
Target $8
ROTH
Buy
Galectin Therapeutics price target raised to $8 from $3 at Roth Capital
Roth Capital analyst Yasmeen Rahimi raised her price target for Galectin Therapeutics to $8 from $3 after the company announced its $10M unsecured line of credit from Richard Uihlein, new director and long-term shareholder, and 1M stock purchase warrants exercisable at $5/share. The analyst believes this was a needed change and the best strategic choice in eliminating financial pressure through 2019, favorably positioning Galectin Therapeutics in potentially securing a lucrative partnership. Rahimi reiterates a Buy rating on the shares.
05/15/18
HCWC
05/15/18
NO CHANGE
Target $12
HCWC
Buy
Galectin Therapeutics price target raised to $12 from $10 at H.C. Wainwright
H.C. Wainwright analyst Ed Arce raised his price target for Galectin Therapeutics to $12 after the company said it is proceeding with plans for a Phase 3 clinical trial program with galectin-3 inhibitor GR-MD-02 in NASH cirrhosis, following a meeting with the FDA earlier this month. Yesterday's announcement is the most meaningful stock catalyst since the top-line results of the Phase 2b NASH-CX trial in early December 2017, Arce tells investors in a research note. The analyst keeps a Buy rating on Galectin.

TODAY'S FREE FLY STORIES

STZ

Constellation Brands

$172.45

-3.61 (-2.05%)

13:55
12/18/18
12/18
13:55
12/18/18
13:55
Options
Constellation Brands put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

MU

Micron

$34.81

0.92 (2.71%)

, UMC

UMC

$1.81

-0.005 (-0.28%)

13:50
12/18/18
12/18
13:50
12/18/18
13:50
On The Fly
Fly Intel: What to watch for in Micron's earnings report »

Micron (MU) is scheduled…

MU

Micron

$34.81

0.92 (2.71%)

UMC

UMC

$1.81

-0.005 (-0.28%)

INTC

Intel

$48.04

0.95 (2.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 04

    Jan

  • 07

    Jan

  • 08

    Jan

VOD

Vodafone

$19.88

-0.13 (-0.65%)

13:48
12/18/18
12/18
13:48
12/18/18
13:48
Periodicals
Vodafone preparing to remove PwC as auditor, Sky News reports »

Vodafone is preparing to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOGL

Alphabet Class A

$1,057.23

30.69 (2.99%)

, GOOG

Alphabet

$1,046.01

28.41 (2.79%)

13:40
12/18/18
12/18
13:40
12/18/18
13:40
Periodicals
Search engine startup claims Google still blocking competition, TechCrunch says »

The European Commission…

GOOGL

Alphabet Class A

$1,057.23

30.69 (2.99%)

GOOG

Alphabet

$1,046.01

28.41 (2.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

KMX

CarMax

$60.38

0.11 (0.18%)

13:40
12/18/18
12/18
13:40
12/18/18
13:40
Options
7X average daily option volume in CarMax driven by an earnings hedge »

7X average daily option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

  • 31

    Jan

  • 01

    Feb

BIDU

Baidu

$169.94

0.03 (0.02%)

13:35
12/18/18
12/18
13:35
12/18/18
13:35
Hot Stocks
Unity Technologies, Baidu partner to develop autonomous vehicle simulation »

Unity Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$131.11

2 (1.55%)

13:32
12/18/18
12/18
13:32
12/18/18
13:32
Periodicals
J&J settles woman's talc cancer case for over $1.5M, Bloomberg reports »

Johnson & Johnson,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 27

    Jan

ORGS

Orgenesis

$4.84

-0.11 (-2.22%)

13:31
12/18/18
12/18
13:31
12/18/18
13:31
Hot Stocks
Orgenesis announces collaboration with MangoGen Pharma »

Orgenesis announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNN

Smith & Nephew

$36.67

-0.38 (-1.03%)

13:27
12/18/18
12/18
13:27
12/18/18
13:27
Hot Stocks
Smith & Nephew buys Ceterix Orthopaedics for $50M initial consideration »

Smith & Nephew…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALB

Albemarle

$81.62

1.12 (1.39%)

13:26
12/18/18
12/18
13:26
12/18/18
13:26
Hot Stocks
Albemarle higher after Hedgeye names new Best Idea Long »

Shares of Albemarle are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTWO

Take-Two

$104.09

1.87 (1.83%)

, ATVI

Activision Blizzard

$47.54

0.45 (0.96%)

13:24
12/18/18
12/18
13:24
12/18/18
13:24
On The Fly
Game On: Wedbush's Pachter says 'Red Dead 2' performing better than he expected »

SUCCESS OF 'RED DEAD 2':…

TTWO

Take-Two

$104.09

1.87 (1.83%)

ATVI

Activision Blizzard

$47.54

0.45 (0.96%)

EA

Electronic Arts

$81.22

2.01 (2.54%)

NTDOY

Nintendo

$0.00

(0.00%)

MSFT

Microsoft

$104.06

1.08 (1.05%)

SNE

Sony

$50.06

-0.425 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jan

  • 03

    Mar

  • 04

    Mar

13:20
12/18/18
12/18
13:20
12/18/18
13:20
Options
Put buying in PHLX Gold and Silver Mining Index as the sector sees strength »

Put buying in PHLX Gold…

APHA

Aphria

$5.98

0.54 (9.93%)

13:18
12/18/18
12/18
13:18
12/18/18
13:18
Hot Stocks
Citron expects 'major partnership or total buyout' soon for Aphria 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$6.01

0.57 (10.48%)

, IGC

India Globalization Capital

$0.00

(0.00%)

13:17
12/18/18
12/18
13:17
12/18/18
13:17
Hot Stocks
Citron mentions Aphria positively again, says 'everything changed' in cannabis 

Reference Link

APHA

Aphria

$6.01

0.57 (10.48%)

IGC

India Globalization Capital

$0.00

(0.00%)

CANN

General Cannabis

$0.00

(0.00%)

CGC

Canopy Growth

$29.00

-0.365 (-1.24%)

MLCPF

MediPharm Labs

$0.00

(0.00%)

CRON

Cronos Group

$11.64

0.52 (4.68%)

TLRY

Tilray

$74.39

8.5 (12.90%)

CVSI

CV Sciences

$0.00

(0.00%)

CNTTF

CannTrust Holdings

$0.00

(0.00%)

ACB

Aurora Cannabis

$5.55

0.01 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$6.01

0.57 (10.48%)

13:17
12/18/18
12/18
13:17
12/18/18
13:17
Periodicals
Breaking Periodicals news story on Aphria »

Citron Research sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
12/18/18
12/18
13:17
12/18/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
12/18/18
12/18
13:16
12/18/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLSN

Nielsen

$24.98

-0.32 (-1.26%)

13:15
12/18/18
12/18
13:15
12/18/18
13:15
Options
Nielsen put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$12.56

-1.89 (-13.08%)

13:14
12/18/18
12/18
13:14
12/18/18
13:14
Hot Stocks
Vintage says Rent-A-Center termination invalid, sees merger pact as in effect »

Vintage Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

RCII

Rent-A-Center

$12.67

-1.78 (-12.32%)

13:13
12/18/18
12/18
13:13
12/18/18
13:13
Hot Stocks
Breaking Hot Stocks news story on Rent-A-Center »

Vintage Capital believes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

RCII

Rent-A-Center

$12.67

-1.78 (-12.32%)

13:12
12/18/18
12/18
13:12
12/18/18
13:12
Hot Stocks
Breaking Hot Stocks news story on Rent-A-Center »

Vintage Capital says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

ISCA

International Speedway

$43.26

0.12 (0.28%)

13:10
12/18/18
12/18
13:10
12/18/18
13:10
Periodicals
Billionaire John Henry interested in Nascar stake, Bloomberg reports »

Billionaire and Boston…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:10
12/18/18
12/18
13:10
12/18/18
13:10
General news
FOMC began its 2-day meeting amid myriad controversies »

FOMC began its 2-day…

RCII

Rent-A-Center

$12.72

-1.73 (-11.97%)

13:09
12/18/18
12/18
13:09
12/18/18
13:09
Upgrade
Rent-A-Center rating change  »

Rent-A-Center upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

CSCO

Cisco

$44.25

0.04 (0.09%)

, AAOI

Applied Optoelectronics

$16.24

-0.89 (-5.20%)

13:05
12/18/18
12/18
13:05
12/18/18
13:05
Recommendations
Cisco, Applied Optoelectronics, Finisar analyst commentary  »

Luxtera buyout negative…

CSCO

Cisco

$44.25

0.04 (0.09%)

AAOI

Applied Optoelectronics

$16.24

-0.89 (-5.20%)

FNSR

Finisar

$21.76

0.2 (0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 04

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.